RLAY · Relay Therapeutics Inc
United States · RS rating 70 · As of 2026-11-03
| Price | 17.44 USD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 35 / 43 / 96 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 41 / 57 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +25.6% |
| Sales growth Q/Q | -57.1% |
| Distance from 52-week high | +15.9% |
| Market cap (USD) | $2.7B |